
Anna Pagonakis
Examiner (ID: 15443, Phone: (571)270-3505 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 6221, 1628, OPET, 4173, 1614, 1609 |
| Total Applications | 1249 |
| Issued Applications | 445 |
| Pending Applications | 84 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6102601
[patent_doc_number] => 20110166094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 12/940457
[patent_app_country] => US
[patent_app_date] => 2010-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13453
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166094.pdf
[firstpage_image] =>[orig_patent_app_number] => 12940457
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/940457 | Agonists of A2A adenosine receptors for treating recurrent tumor growth | Nov 4, 2010 | Issued |
Array
(
[id] => 8393173
[patent_doc_number] => 20120231015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'FRAGILE X MENTAL RETARDATION PROTEIN (FMRP), COMPOSITIONS, AND METHODS RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 13/505913
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21315
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505913
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/505913 | FRAGILE X MENTAL RETARDATION PROTEIN (FMRP), COMPOSITIONS, AND METHODS RELATED THERETO | Nov 3, 2010 | Abandoned |
Array
(
[id] => 6071382
[patent_doc_number] => 20110046233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'GOSSYPOL DERIVATIVES, PRODUCTION METHOD THEREOF AND USES OF SAME'
[patent_app_type] => utility
[patent_app_number] => 12/939326
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3589
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046233.pdf
[firstpage_image] =>[orig_patent_app_number] => 12939326
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/939326 | GOSSYPOL DERIVATIVES, PRODUCTION METHOD THEREOF AND USES OF SAME | Nov 3, 2010 | Abandoned |
Array
(
[id] => 8696913
[patent_doc_number] => 20130058922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE'
[patent_app_type] => utility
[patent_app_number] => 13/508159
[patent_app_country] => US
[patent_app_date] => 2010-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4819
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508159
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508159 | PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE | Nov 2, 2010 | Abandoned |
Array
(
[id] => 9355447
[patent_doc_number] => 08673980
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Closthioamides, compositions, and methods for treating bacterial or fungal infections or cancer'
[patent_app_type] => utility
[patent_app_number] => 13/504990
[patent_app_country] => US
[patent_app_date] => 2010-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 10000
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504990
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/504990 | Closthioamides, compositions, and methods for treating bacterial or fungal infections or cancer | Nov 1, 2010 | Issued |
Array
(
[id] => 8721240
[patent_doc_number] => 20130072458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'Methods of Treating Viral Associated Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/504785
[patent_app_country] => US
[patent_app_date] => 2010-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 45139
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/504785 | Methods of Treating Viral Associated Diseases | Oct 28, 2010 | Abandoned |
Array
(
[id] => 5986771
[patent_doc_number] => 20110098258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Transdermal Pharmaceutical Compositions Comprising Active Agents'
[patent_app_type] => utility
[patent_app_number] => 12/912310
[patent_app_country] => US
[patent_app_date] => 2010-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20450
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098258.pdf
[firstpage_image] =>[orig_patent_app_number] => 12912310
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/912310 | Transdermal pharmaceutical compositions comprising active agents | Oct 25, 2010 | Issued |
Array
(
[id] => 5986699
[patent_doc_number] => 20110098232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Methods For The Selective Treatment Of Tumors By Calcium-Mediated Induction Of Apoptosis'
[patent_app_type] => utility
[patent_app_number] => 12/911723
[patent_app_country] => US
[patent_app_date] => 2010-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6961
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098232.pdf
[firstpage_image] =>[orig_patent_app_number] => 12911723
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/911723 | Methods For The Selective Treatment Of Tumors By Calcium-Mediated Induction Of Apoptosis | Oct 24, 2010 | Abandoned |
Array
(
[id] => 8442380
[patent_doc_number] => 20120258997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'NEW APPLICATION OF 2-PYRROLIDONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/503556
[patent_app_country] => US
[patent_app_date] => 2010-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2607
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503556
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503556 | Use of piracetam for treating diabetic nephropathy | Oct 22, 2010 | Issued |
Array
(
[id] => 8430988
[patent_doc_number] => 20120252863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'TRIPTANS FOR THE TREATMENT OF PSORIASIS'
[patent_app_type] => utility
[patent_app_number] => 13/503418
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4797
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503418
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503418 | Triptans for the treatment of psoriasis | Oct 21, 2010 | Issued |
Array
(
[id] => 5954306
[patent_doc_number] => 20110034494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'REVERSIBLE INHIBITION OF SPERM RECEPTOR SYNTHESIS FOR CONTRACEPTION'
[patent_app_type] => utility
[patent_app_number] => 12/910098
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4871
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034494.pdf
[firstpage_image] =>[orig_patent_app_number] => 12910098
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/910098 | REVERSIBLE INHIBITION OF SPERM RECEPTOR SYNTHESIS FOR CONTRACEPTION | Oct 21, 2010 | Abandoned |
Array
(
[id] => 8442354
[patent_doc_number] => 20120258970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'Compositions and Methods for the Treatment of Drug-Induced Hand-Foot Syndrome'
[patent_app_type] => utility
[patent_app_number] => 13/502209
[patent_app_country] => US
[patent_app_date] => 2010-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5944
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502209
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/502209 | Compositions and methods for the treatment of drug-induced hand-foot syndrome | Oct 14, 2010 | Issued |
Array
(
[id] => 8503238
[patent_doc_number] => 20120302645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'USE OF HYDROXYTYROSOL FOR IMPROVING MUSCLE DIFFERENTIATION'
[patent_app_type] => utility
[patent_app_number] => 13/500740
[patent_app_country] => US
[patent_app_date] => 2010-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 7287
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500740
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/500740 | USE OF HYDROXYTYROSOL FOR IMPROVING MUSCLE DIFFERENTIATION | Oct 7, 2010 | Abandoned |
Array
(
[id] => 8442330
[patent_doc_number] => 20120258944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'ANTIOXIDANTS FOR USE IN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/499872
[patent_app_country] => US
[patent_app_date] => 2010-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 11161
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499872
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/499872 | ANTIOXIDANTS FOR USE IN THERAPY | Oct 3, 2010 | Abandoned |
Array
(
[id] => 6079834
[patent_doc_number] => 20110142756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/897366
[patent_app_country] => US
[patent_app_date] => 2010-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 83
[patent_figures_cnt] => 83
[patent_no_of_words] => 23591
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142756.pdf
[firstpage_image] =>[orig_patent_app_number] => 12897366
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/897366 | Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer | Oct 3, 2010 | Abandoned |
Array
(
[id] => 8465715
[patent_doc_number] => 20120270884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/497726
[patent_app_country] => US
[patent_app_date] => 2010-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16831
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497726
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/497726 | Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors | Sep 29, 2010 | Abandoned |
Array
(
[id] => 6150028
[patent_doc_number] => 20110021623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'SYSTEM AND METHODS OF MELANOMA PREVENTION'
[patent_app_type] => utility
[patent_app_number] => 12/895227
[patent_app_country] => US
[patent_app_date] => 2010-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1804
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021623.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895227
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895227 | SYSTEM AND METHODS OF MELANOMA PREVENTION | Sep 29, 2010 | Abandoned |
Array
(
[id] => 5944981
[patent_doc_number] => 20110105601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'COMPOSITIONS FOR USE IN TREATING OR PREVENTING METABOLIC STRESS-INDUCED LUNG INJURY AND METHODS FOR INCREASING PHYSICAL CAPACITY OF MAMMALIAN LIVESTOCK'
[patent_app_type] => utility
[patent_app_number] => 12/892431
[patent_app_country] => US
[patent_app_date] => 2010-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7320
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105601.pdf
[firstpage_image] =>[orig_patent_app_number] => 12892431
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/892431 | COMPOSITIONS FOR USE IN TREATING OR PREVENTING METABOLIC STRESS-INDUCED LUNG INJURY AND METHODS FOR INCREASING PHYSICAL CAPACITY OF MAMMALIAN LIVESTOCK | Sep 27, 2010 | Abandoned |
Array
(
[id] => 5937633
[patent_doc_number] => 20110212978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'Combination of ZD6474 and Pemetrexed'
[patent_app_type] => utility
[patent_app_number] => 12/892478
[patent_app_country] => US
[patent_app_date] => 2010-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7661
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212978.pdf
[firstpage_image] =>[orig_patent_app_number] => 12892478
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/892478 | Combination of ZD6474 and Pemetrexed | Sep 27, 2010 | Abandoned |
Array
(
[id] => 6201962
[patent_doc_number] => 20110064748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'PHARMACEUTICAL COMBINATION AND METHOD FOR TREATING TUMOR'
[patent_app_type] => utility
[patent_app_number] => 12/882794
[patent_app_country] => US
[patent_app_date] => 2010-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7307
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20110064748.pdf
[firstpage_image] =>[orig_patent_app_number] => 12882794
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/882794 | Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor | Sep 14, 2010 | Issued |